https://openbell.ai/ 2026-10-06T10:38:57.772Z hourly 1.0 https://openbell.ai/support 2026-10-06T10:38:57.772Z monthly 0.7 https://openbell.ai/privacy 2026-10-06T10:38:57.772Z monthly 0.5 https://openbell.ai/terms 2026-10-06T10:38:57.772Z monthly 0.5 https://openbell.ai/feed.json 2026-10-06T10:38:57.772Z hourly 0.8 https://openbell.ai/news/GOOGL:1791283107830 2026-10-06T10:38:27.830Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Unleashes AI on Aging Enterprise Tech With New Cloud Modernization Suite Alphabet Inc. has launched the Google Cloud Modernize suite, aimed at helping enterprises modernize their infrastructure and applications using AI, which includes tools like Migration Center and the EKS-to-GKE Migration Agent. The company also introduced new infrastructure to support demanding enterprise workloads, including the X5 Series for SAP configurations and M4N Series for database workloads. Despite these advancements, Alphabet faces increased competition in consumer AI, particularly from Meta Platforms, which has gained significant traction with its personal AI agents. Alphabet's shares were up 0.42% at $345.26 in premarket trading. https://openbell.ai/news/ZGN:1791283014963 2026-10-06T10:36:54.963Z daily 0.9 https://cdn.brandfetch.io/ZGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud HSBC Initiates Coverage On Ermenegildo Zegna with Buy Rating, Announces Price Target of $16 HSBC analyst Bhumi Kanabar has initiated coverage on Ermenegildo Zegna (NYSE: ZGN) with a Buy rating. The firm has set a price target of $16 for the stock. https://openbell.ai/news/BJDX:1791282972947 2026-10-06T10:36:12.947Z daily 0.9 https://cdn.brandfetch.io/BJDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bluejay Diagnostics Reports SYMON-II Baseline Data Showing Diverse Critically Ill Sepsis Population And Meaningful Mortality Events Supporting IL-6 Evaluation For 28-Day Mortality Risk Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported baseline data from its SYMON-II clinical validation study, which includes 777 evaluable patients with an overall 28-day mortality rate of approximately 18%. The study highlighted a diverse population of critically ill patients, with 39.5% meeting Sepsis-3 criteria for septic shock. Among non-survivors, 56.4% had septic shock, indicating greater baseline illness severity compared to survivors. The findings support the evaluation of interleukin-6 (IL-6) as a biomarker for 28-day mortality risk in sepsis patients. https://openbell.ai/news/XP:1791282930558 2026-10-06T10:35:30.558Z daily 0.9 https://cdn.brandfetch.io/XP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Itau BBA Upgrades XP to Outperform, Announces $27 Price Target Itau BBA analyst Pedro Leduc has upgraded XP (NASDAQ: XP) from Market Perform to Outperform, setting a price target of $27 for the stock. This upgrade indicates a positive outlook for XP's performance in the market. https://openbell.ai/news/SRFM:1791282852236 2026-10-06T10:34:12.236Z daily 0.9 https://cdn.brandfetch.io/SRFM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Surf Air Mobility Signs Definitive Agreement With Clipper Aviation For OperatorOS, Surf Air Mobility's SurfOS Flight Operations Software For Part 135 Operators Powered By Palantir Surf Air Mobility has signed a definitive agreement with Clipper Aviation for its OperatorOS flight operations software, marking the fourth such contract for the company. This agreement aims to help Surf Air Mobility achieve its goal of having five operators using the platform by the end of 2026. The company will earn a percentage of revenue from all Clipper Aviation flights managed through the OperatorOS software. https://openbell.ai/news/CEG:1791282780067 2026-10-06T10:33:00.067Z daily 0.9 https://cdn.brandfetch.io/CEG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google And Constellation Energy Announce Long-Term Strategic Clean Energy Collaboration To Bring 890 MW Of Reliable Nuclear Capacity Onto PJM Interconnection Grid To Meet Growing Demand And Increase Grid Reliability Google and Constellation Energy have announced a long-term collaboration to add 890 megawatts (MW) of nuclear capacity to the PJM Interconnection grid through a 20-year power purchase agreement. This initiative will involve investments exceeding $4.3 billion in new technology at 11 nuclear units, sustaining approximately 4,400 jobs and creating around 7,200 construction jobs. Additionally, the partnership includes a 15-year energy supply agreement for an extra 2,700 MW and a five-year technology alliance to implement AI solutions for energy management. https://openbell.ai/news/LMT:1791282689829 2026-10-06T10:31:29.829Z daily 0.9 https://cdn.brandfetch.io/LMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rothschild & Co Initiates Coverage On Lockheed Martin with Buy Rating, Announces Price Target of $650 Rothschild & Co has initiated coverage on Lockheed Martin (NYSE: LMT) with a Buy rating. The firm has set a price target of $650 for the company's stock. https://openbell.ai/news/TLX:1791282684382 2026-10-06T10:31:24.382Z daily 0.9 https://cdn.brandfetch.io/TLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Telix Pharmaceuticals Says First Patients In US Dosed With Pixclara, FDA-Approved, Amino Acid Positron Emission Tomography Drug For Glioma Imaging Telix Pharmaceuticals has announced the first doses of its FDA-approved drug Pixclara, an amino acid positron emission tomography (PET) agent for glioma imaging, have been administered in the U.S. at facilities in Cleveland and Indianapolis. This marks the beginning of Pixclara's commercial availability in the U.S., with PharmaLogic Holdings Corp. as the distribution partner. Pixclara is designed to help differentiate recurrent or progressive glioma from treatment-related changes in patients aged one month and older. https://openbell.ai/news/BTC:1791282662511 2026-10-06T10:31:02.511Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Hunter-Biden-Addressed-The-Media-On-Dece.jpg?width=250&height=187 Hunter Biden Says America’s Dollar Is ‘Fake’ Under Fiat System, Warns Inflation Is Built in When Government Can Print Money ‘at Will’ Hunter Biden criticized the U.S. dollar, labeling it 'fake' and asserting that inflation acts as a built-in tax under the fiat monetary system. He emphasized his pro-Bitcoin stance, stating that 'fiat is a sham' and predicting Bitcoin could reach $220,000 by 2028. Biden's recent comments align with his previous views on cryptocurrency and reflect a growing alignment with the Bitcoin community, particularly following the launch of his LAPTOP token in September. https://openbell.ai/news/APOG:1791282657899 2026-10-06T10:30:57.899Z daily 0.9 https://cdn.brandfetch.io/APOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apogee Enterprises Raises FY2027 Adj EPS Guidance from $2.70-$3.25 to $3.00-$3.40 vs $2.92 Est; Raises FY2027 Sales Guidance from $1.380B-$1.430B to $1.460B-$1.500B vs $1.458B Est Apogee Enterprises has raised its fiscal year 2027 adjusted EPS guidance from a range of $2.70-$3.25 to $3.00-$3.40, surpassing the analyst estimate of $2.92. Additionally, the company increased its sales outlook for FY2027 from $1.380 billion-$1.430 billion to $1.460 billion-$1.500 billion, slightly above the $1.458 billion estimate. https://openbell.ai/news/APOG:1791282656162 2026-10-06T10:30:56.162Z daily 0.9 https://cdn.brandfetch.io/APOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Apogee Enterprises Q2 Adj. EPS $1.17 Beats $0.63 Estimate, Sales $391.135M Beat $359.464M Estimate Apogee Enterprises reported Q2 adjusted earnings per share of $1.17, surpassing the analyst estimate of $0.63 by 85.71%. This represents a 19.39% increase compared to $0.98 per share from the same quarter last year. The company's sales reached $391.135 million, exceeding the expected $359.464 million by 8.81%, and marking a 9.20% increase from $358.194 million in the prior year. https://openbell.ai/news/NOC:1791282616156 2026-10-06T10:30:16.156Z daily 0.9 https://cdn.brandfetch.io/NOC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rothschild & Co Initiates Coverage On Northrop Grumman with Buy Rating, Announces Price Target of $680 Rothschild & Co has initiated coverage on Northrop Grumman (NYSE: NOC) with a Buy rating. The firm has set a price target of $680 for the stock. https://openbell.ai/news/KSA:1791282570675 2026-10-06T10:29:30.675Z daily 0.9 https://cdn.brandfetch.io/KSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Earlier, 'Two Saudi airports targeted on Monday as fighting with Yemen's Houthis escalates' - Reuters On October 6, 2026, two airports in Saudi Arabia were targeted amid escalating fighting with Yemen's Houthi forces. This incident raises concerns about regional stability and could impact the operations and security of the aviation sector in Saudi Arabia. The situation may lead to fluctuations in stock prices for companies operating in the region, including those listed under the KSA ticker. https://openbell.ai/news/KTOS:1791282534103 2026-10-06T10:28:54.103Z daily 0.9 https://cdn.brandfetch.io/KTOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rothschild & Co Initiates Coverage On Kratos Defense & Security with Buy Rating, Announces Price Target of $70 Rothschild & Co has initiated coverage on Kratos Defense & Security (NASDAQ: KTOS) with a Buy rating. The firm has set a price target of $70 for the stock. https://openbell.ai/news/GSHD:1791282278916 2026-10-06T10:24:38.916Z daily 0.9 https://cdn.brandfetch.io/GSHD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Downgrades Goosehead Insurance to Neutral, Lowers Price Target to $48 Piper Sandler analyst Paul Newsome has downgraded Goosehead Insurance (NASDAQ: GSHD) from Overweight to Neutral. The price target for the stock has been reduced from $72 to $48. https://openbell.ai/news/NTSK:1791282128284 2026-10-06T10:22:08.284Z daily 0.9 https://cdn.brandfetch.io/NTSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Netskope, Raises Price Target to $22 BTIG analyst Gray Powell has maintained a Buy rating on Netskope (NASDAQ: NTSK) and increased the price target from $18 to $22. https://openbell.ai/news/VFS:1791282107225 2026-10-06T10:21:47.225Z daily 0.9 https://cdn.brandfetch.io/VFS/w/400/h/400?c=1idopYfmtR7ZKg8QMud VinFast Announced Partnership With NexMove Certified To Bring All-Electric Bus Models To U.S. Market At APTA 2026 TRANSform & EXPO openbell Financial News https://openbell.ai/news/NET:1791282080641 2026-10-06T10:21:20.641Z daily 0.9 https://cdn.brandfetch.io/NET/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Cloudflare, Raises Price Target to $413 BTIG analyst Gray Powell has maintained a Buy rating on Cloudflare (NYSE: NET) and increased the price target from $382 to $413. This adjustment reflects positive sentiment towards the company's performance and growth potential. https://openbell.ai/news/GLD:1791281961806 2026-10-06T10:19:21.806Z daily 0.9 https://cdn.brandfetch.io/GLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Retail Market (Still) Mostly Ignores The ‘Hedge Against All Human Stupidity’ Gold prices are currently holding above $4,000 an ounce despite rising Treasury yields, which have reached multi-decade highs. The SPDR Gold Shares ETF (GLD) is down 4.7% year-to-date, while the iShares 20+ Year Treasury Bond ETF (TLT) has slid 11.4%. Central banks have reported net purchases of 170 tons of gold so far this year, with Poland leading at 98 tons, while retail investor participation remains low. The gold market is experiencing a structural shift, with increased central bank demand and a focus on diversifying reserves amid geopolitical risks. https://openbell.ai/news/HPK:1791281945878 2026-10-06T10:19:05.878Z daily 0.9 https://cdn.brandfetch.io/HPK/w/400/h/400?c=1idopYfmtR7ZKg8QMud HighPeak Energy Announces Refinancing Via $450M Preferred Equity Investment And An $800M Credit Facility HighPeak Energy has announced a refinancing plan that includes a $450 million investment from PT Danantara Investment Management and PT Energi Mega Persada, which will involve the issuance of 450,000 shares of convertible preferred stock. Additionally, the company has secured an $800 million reserve-based credit facility from Citibank and Fifth Third Bank, aimed at repaying its existing $1.17 billion term loan. The investment is expected to close in the fourth quarter of 2026, subject to customary conditions, and will allow the investors to appoint directors to HighPeak's Board. https://openbell.ai/news/CBIO:1791281885155 2026-10-06T10:18:05.155Z daily 0.9 https://cdn.brandfetch.io/CBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Upgrades Crescent Biopharma to Buy, Announces $36 Price Target HC Wainwright & Co. has upgraded Crescent Biopharma (NASDAQ: CBIO) from a Neutral rating to a Buy rating. The firm has set a price target of $36 for the company's stock. https://openbell.ai/news/KRRO:1791281771561 2026-10-06T10:16:11.561Z daily 0.9 https://cdn.brandfetch.io/KRRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $15 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Korro Bio (NASDAQ: KRRO) and maintained a price target of $15 for the stock. https://openbell.ai/news/AIIO:1791281715096 2026-10-06T10:15:15.096Z daily 0.9 https://cdn.brandfetch.io/AIIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Robo.ai Reports Preliminary September Sales Of $100M+; Expects FY26 Sales Of ~$600M Based On YtD Performance Robo.ai reported preliminary sales of over $100 million for September and anticipates full-year 2026 sales of approximately $600 million, supported by stable operations from its acquisition of QC Capital. The company is advancing its AI capabilities through Neurovia AI and is progressing with the development of an industrial park in Umm Al Quwain, UAE, which aims to enhance local manufacturing and systems integration. QC Capital's contributions are expected to bolster Robo.ai's revenue base as it integrates its operations and focuses on disciplined growth. https://openbell.ai/news/KBR:1791281690882 2026-10-06T10:14:50.882Z daily 0.9 https://cdn.brandfetch.io/KBR/w/400/h/400?c=1idopYfmtR7ZKg8QMud KBR Awarded Aramco Project To Support Upgrade Of Facilities Across Marjan Offshore Field In Arabian Gulf; Terms Not Disclosed openbell Financial News https://openbell.ai/news/ZS:1791281595959 2026-10-06T10:13:15.959Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zscaler reaffirms Q1adjusted EPS of ~$1.15-$1.16 and sales of $935M-$939M; Reaffirms FY27 adjusted EPS of $4.86-$4.90 and sales of $3.908B-$3.938B Zscaler reaffirmed its first quarter fiscal 2027 guidance, expecting revenue between $935 million and $939 million, with a year-over-year growth of approximately 19%. The company also projected a non-GAAP net income per share of $1.15 to $1.16. For the full fiscal year 2027, Zscaler anticipates revenue of $3.908 billion to $3.938 billion, reflecting a growth of 16.6% to 17.5%, and a non-GAAP net income per share of $4.86 to $4.90. https://openbell.ai/news/EXPE:1791281494941 2026-10-06T10:11:34.941Z daily 0.9 https://cdn.brandfetch.io/EXPE/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on Expedia Group, Maintains $400 Price Target BTIG analyst Jake Fuller has reiterated a 'Buy' rating on Expedia Group (NASDAQ: EXPE) and maintained a price target of $400 for the stock. This endorsement suggests confidence in the company's future performance. https://openbell.ai/news/RDDT:1791281449349 2026-10-06T10:10:49.349Z daily 0.9 https://cdn.brandfetch.io/RDDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reddit Launched Enhanced Capabilities for Lead Generation Reddit has introduced enhanced capabilities aimed at improving lead generation for businesses using its platform. This initiative is part of Reddit's strategy to attract more advertisers and increase revenue. The enhancements include new tools and features designed to facilitate better targeting and engagement with potential customers. The stock ticker for Reddit is RDDT. https://openbell.ai/news/POLA:1791281376890 2026-10-06T10:09:36.890Z daily 0.9 https://cdn.brandfetch.io/POLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Solidion Technology Declines To Increase Its Offer To Acquire Polar Power Following Board's Rejection Solidion Technology, Inc. has decided not to increase its acquisition offer for Polar Power, Inc. after the latter's Board rejected the all-cash proposal. Polar Power is facing significant financial challenges, including a net loss of approximately $2.0 million for the first half of 2026 and ongoing compliance issues with NASDAQ. Solidion emphasizes its commitment to disciplined financial modeling and maximizing shareholder value, stating that it will not overpay for acquisitions, particularly for a company as distressed as Polar Power. https://openbell.ai/news/AMC:1791281345922 2026-10-06T10:09:05.922Z daily 0.9 https://cdn.brandfetch.io/AMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud AMC Completes $3.97B Debt Refinancing, Extends Maturities To 2031, 2033 openbell Financial News https://openbell.ai/news/PRAX:1791281276907 2026-10-06T10:07:56.907Z daily 0.9 https://cdn.brandfetch.io/PRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826 BTIG analyst Kambiz Yazdi has maintained a Buy rating on Praxis Precision Medicine (NASDAQ: PRAX) and increased the price target from $810 to $826. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/PENN:1791281235469 2026-10-06T10:07:15.469Z daily 0.9 https://cdn.brandfetch.io/PENN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Upgrades PENN Entertainment to Buy, Raises Price Target to $25 Deutsche Bank analyst Carlo Santarelli has upgraded PENN Entertainment (NASDAQ: PENN) from a Hold rating to a Buy rating. Additionally, the price target for the stock has been raised from $23 to $25. https://openbell.ai/news/NEO:1791281041728 2026-10-06T10:04:01.728Z daily 0.9 https://cdn.brandfetch.io/NEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Upgrades NeoGenomics to Buy, Announces $28 Price Target BTIG analyst Mark Massaro has upgraded NeoGenomics (NASDAQ: NEO) from a Neutral rating to a Buy rating. The firm has set a price target of $28 for the stock. https://openbell.ai/news/APLD:1791281030549 2026-10-06T10:03:50.549Z daily 0.9 https://cdn.brandfetch.io/APLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Applied Digital To Provide Access To Up To 1 GW Of Potential Power Capacity In Finland, The Company’s First Development Opportunity Outside The U.S. Applied Digital has announced plans to develop a large-scale AI Factory campus in Finland, with the potential to scale up to 1 GW of power capacity, marking its first international development outside the U.S. Initial power availability is expected in 2028, and the company is currently marketing the site to global hyperscale customers. This move is part of a strategy to selectively expand into international markets while maintaining a focus on its U.S. portfolio. The project will proceed based on customer demand and regulatory requirements. https://openbell.ai/news/PSNL:1791280935030 2026-10-06T10:02:15.030Z daily 0.9 https://cdn.brandfetch.io/PSNL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Downgrades Personalis to Neutral BTIG analyst Mark Massaro has downgraded Personalis (NASDAQ: PSNL) from a Buy rating to Neutral. This change reflects a shift in the analyst's outlook on the company's performance. https://openbell.ai/news/KKR:1791280882451 2026-10-06T10:01:22.451Z daily 0.9 https://cdn.brandfetch.io/KKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud KKR Eyes Private Markets Gold Rush With $5.1 Billion Gen II Deal KKR & Co. Inc. has agreed to acquire Gen II Fund Services LLC for $5.1 billion, with the deal expected to close in 2027 pending regulatory approvals. Gen II provides fund administration services to over 275 investment managers, managing more than $2 trillion in assets. KKR plans to enhance Gen II's growth in the U.S. and internationally while investing in technology and AI tools. KKR's stock closed at $89.96, down 0.37%, with upcoming earnings expected to show a rise in earnings per share to $1.59. https://openbell.ai/news/KKR:1791280873410 2026-10-06T10:01:13.410Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/KKR-investment-firm.jpg?width=250&height=187 KKR Eyes Private Markets Gold Rush With $5.1 Billion Gen II Deal KKR & Co. Inc. has agreed to acquire Gen II Fund Services LLC for $5.1 billion, with the transaction expected to close in 2027, pending regulatory approvals. Gen II provides fund administration services to over 275 investment managers, managing more than $2 trillion in assets, and KKR plans to support its expansion and invest in technology. KKR's cash and short-term investments were reported at $5.3 billion as of Q2, and it is scheduled to report earnings on November 9, with projected earnings of $1.59 per share. https://openbell.ai/news/PLD:1791280867256 2026-10-06T10:01:07.256Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Analysts-Compare-Overvaluation-To-Previo.jpg?width=250&height=187 Top Wall Street Forecasters Revamp Prologis Expectations Ahead Of Q3 Earnings Prologis, Inc. (NYSE: PLD) is set to release its Q3 earnings report on October 15, with analysts predicting earnings of 78 cents per share, a decrease from 80 cents per share in the same quarter last year. The expected revenue for the quarter is $2.22 billion, up from $2.05 billion a year ago. Recently, Prologis announced a public offering of 15 million shares valued at approximately $2.1 billion. Following this news, Prologis shares fell by 0.6% to close at $128.08. https://openbell.ai/news/BYD:1791280784917 2026-10-06T09:59:44.917Z daily 0.9 https://cdn.brandfetch.io/BYD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Upgrades Boyd Gaming to Buy, Raises Price Target to $99 Deutsche Bank analyst Carlo Santarelli has upgraded Boyd Gaming (NYSE: BYD) from a Hold to a Buy rating. Additionally, the price target for the stock has been raised from $98 to $99. https://openbell.ai/news/KKR:1791280776257 2026-10-06T09:59:36.257Z daily 0.9 https://cdn.brandfetch.io/KKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud KKR Eyes Private Markets Gold Rush With $5.1 Billion Gen II Deal KKR & Co. Inc. has agreed to acquire Gen II Fund Services LLC for $5.1 billion, with the deal expected to close in 2027 pending regulatory approvals. Gen II provides fund administration services to over 275 investment managers, managing more than $2 trillion in assets, and KKR plans to support its expansion and invest in technology. As of Q2, KKR reported $5.3 billion in cash and short-term investments, and its upcoming earnings report is anticipated to show a rise in earnings per share to $1.59 from $1.41 a year earlier. https://openbell.ai/news/TSLA:1791280472315 2026-10-06T09:54:32.315Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Kaunas--Lithuania-2022---April-14-Tesla-.jpg?width=250&height=187 TSLA Stock May Have 'More Near-Term Upside' as Delivery Beat Changes the Math — Gary Black Sees 'Room' Beyond Recent $23-Per-Share Gain Tesla Inc. (NASDAQ: TSLA) reported third-quarter deliveries of 486,532 vehicles, exceeding Wall Street expectations by approximately 25,000 units. Investor Gary Black estimates that this delivery beat could lead to an increase of $0.15 in annual adjusted EPS, potentially raising the stock price by about $32 per share. Following the announcement, TSLA shares rose nearly 5%, closing at $378.73, marking a total increase of 7.55% since last Thursday. Investors are now awaiting Tesla's Q3 earnings report scheduled for October 21. https://openbell.ai/news/CBNA:1791280366234 2026-10-06T09:52:46.234Z daily 0.9 https://cdn.brandfetch.io/CBNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raymond James Upgrades Chain Bridge Bancorp to Outperform, Announces $53 Price Target Raymond James analyst Steve Moss has upgraded Chain Bridge Bancorp (NYSE: CBNA) from Market Perform to Outperform. The firm has set a price target of $53 for the stock. https://openbell.ai/news/TMO:1791280169315 2026-10-06T09:49:29.315Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Doctors--Tablet-And-People-With-Discussi.jpg?width=250&height=187 EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial Quantum BioPharma Ltd. has partnered with Thermo Fisher Scientific Inc. to conduct a Phase 2 clinical trial for its multiple sclerosis treatment, Lucid-MS, following recent FDA clearance. Thermo Fisher's PPD clinical research division will manage the study initiation and provide related services. The trial will evaluate the safety and effectiveness of Lucid-MS in patients with progressive forms of multiple sclerosis, targeting myelin degradation. Quantum BioPharma shares rose 1.15% to $3.30 during premarket trading. https://openbell.ai/news/TSLA:1791280100236 2026-10-06T09:48:20.236Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/06/Tesla-Inc.jpg?width=250&height=187 Tesla’s Delivery Beat Is Just the ‘Appetizer,’ Analyst Says 2027 Could Be the Main Event Tesla Inc. delivered 486,532 vehicles in Q3 2026, exceeding estimates by 5.3%, although this represents a 2.1% decline from last year's record. The company's energy storage deployments fell short of expectations, totaling 13.7 GWh, marking its third consecutive miss. Analysts suggest that Tesla's focus on Full Self-Driving and autonomous technology could drive future demand, with expectations of a 15% increase in deliveries next year, compared to the Street's estimate of 9%. Tesla shares were up 0.51% to $380.65 during premarket trading. https://openbell.ai/news/TMO:1791280095996 2026-10-06T09:48:15.996Z daily 0.9 https://cdn.brandfetch.io/TMO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial Quantum BioPharma Ltd. has partnered with Thermo Fisher Scientific Inc. to initiate a Phase 2 clinical trial for its multiple sclerosis treatment, Lucid-MS, following recent FDA clearance. Thermo Fisher's PPD clinical research division will manage the study's start-up and related services. The trial aims to evaluate the safety and effectiveness of Lucid-MS in patients with progressive forms of multiple sclerosis, focusing on halting myelin degradation. Quantum BioPharma shares rose 1.15% to $3.30 in premarket trading. https://openbell.ai/news/QNTM:1791280072821 2026-10-06T09:47:52.821Z daily 0.9 https://cdn.brandfetch.io/QNTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Quantum BioPharma Contracts With Thermo Fisher Scientific Clinical Research Business To Support Phase 2 Trial For Neuroprotective Therapy In Multiple Sclerosis; Financial Terms Not Disclosed openbell Financial News https://openbell.ai/news/CSGP:1791279910413 2026-10-06T09:45:10.413Z daily 0.9 https://cdn.brandfetch.io/CSGP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on CoStar Group, Maintains $40 Price Target Needham analyst Mayank Tandon has reiterated a Buy rating on CoStar Group (NASDAQ: CSGP) and maintained a price target of $40 for the stock. This endorsement suggests continued confidence in the company's performance and potential for growth. https://openbell.ai/news/APH:1791279880994 2026-10-06T09:44:40.994Z daily 0.9 https://cdn.brandfetch.io/APH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Buy on Amphenol, Raises Price Target to $116 Goldman Sachs analyst Mark Delaney has reiterated a Buy rating on Amphenol (NYSE: APH) and increased the price target from $102 to $116. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/TEL:1791279820478 2026-10-06T09:43:40.478Z daily 0.9 https://cdn.brandfetch.io/TEL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Buy on TE Connectivity, Raises Price Target to $288 Goldman Sachs analyst Mark Delaney has maintained a 'Buy' rating on TE Connectivity (NYSE: TEL) and raised the price target from $284 to $288. This adjustment reflects the firm's positive outlook on the company's performance. https://openbell.ai/news/STDN:1791279734983 2026-10-06T09:42:14.983Z daily 0.9 https://cdn.brandfetch.io/STDN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Initiates Coverage On Standard Nuclear with Buy Rating, Announces Price Target of $18 Needham analyst Sean Milligan has initiated coverage on Standard Nuclear (NYSE: STDN) with a Buy rating. The firm has set a price target of $18 for the company's stock. https://openbell.ai/news/KEYS:1791279667828 2026-10-06T09:41:07.828Z daily 0.9 https://cdn.brandfetch.io/KEYS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goldman Sachs Maintains Buy on Keysight Techs, Raises Price Target to $487 Goldman Sachs analyst Mark Delaney has maintained a 'Buy' rating on Keysight Technologies (NYSE: KEYS) and increased the price target from $452 to $487.